Harnessing oncolytic virus-mediated immunity
Oncolytic viruses (OVs) have emerged as a promising anticancer treatment. OVs selectively infect, replicate in, and kill tumor cells. Oncolytic viral therapy occurs in two phases: an initial phase where the virus mediates direct oncolysis of tumor cells, and a second phase where an induced post-onco...
Saved in:
Main Author: | Volker Schirrmacher (auth) |
---|---|
Other Authors: | Philippe Fournier (auth) |
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Frontiers Media SA
2015
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncolytic Virus Immunotherapy
Published: (2022) -
Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy
by: Benjamin Gesundheit
Published: (2017) -
Epigenetic Modifications and Viral Infections
by: Alejandro Garcia Carranca
Published: (2015) -
NK Cell Subsets in Health and Disease: New Developments
by: Emanuela Marcenaro
Published: (2017) -
Evolution of NK-mediated target recognition under the pressure of physiologic or pathologic stimuli
by: Miguel Lopez-Botet
Published: (2015)